Howard Hughes Medical Institute’s Eli Lilly LLY Stock Holding History

Howard Hughes Medical Institute’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-171	Closed	-$184K	–	294
2025 Q4	$184K	Buy	171 +1	+0.6%	+$956	0.11%	13
2025 Q3	$130K	Hold	170	–	–	0.08%	13
2025 Q2	$133K	Buy	+170	New	+$132K	0.05%	13
2017 Q1	–	Sell	-10,402	Closed	-$765K	–	159
2016 Q4	$765K	Sell	10,402 -3,625	-26%	-$270K	0.17%	80
2016 Q3	$1.13M	Sell	14,027 -4,129	-23%	-$330K	0.29%	67
2016 Q2	$1.43M	Buy	+18,156	New	+$1.37M	0.48%	60
2015 Q3	–	Sell	-2,064	Closed	-$172K	–	169
2015 Q2	$172K	Buy	+2,064	New	+$157K	0.04%	130

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Howard Hughes Medical Institute's LLY Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 171 shares — an estimated $184K sold.

Howard Hughes Medical Institute first reported a position in LLY in Q2 2015 and held it in 7 quarters. The position peaked at $1.43M in Q2 2016. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Howard Hughes Medical Institute reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
Howard Hughes Medical Institute sold 171 Eli Lilly shares in Q1 2026, an estimated $184K.
Howard Hughes Medical Institute first reported a position in Eli Lilly in Q2 2015 and held it in 7 quarters.
Howard Hughes Medical Institute's Eli Lilly position peaked at $1.43M in Q2 2016.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.